Research Alliances
Novo Nordisk
Novo Nordisk is the world’s leading diabetes therapeutics company, with 95 years of experience of innovation in diabetes care. The company has a longstanding relationship with the University of Oxford, itself a global leader in metabolism research, and in 2017 the Novo Nordisk Research Centre Oxford (NNRCO) was launched as part of a strategic alliance between the two organisations.
Pfizer
The shared interest in Rare Diseases between Pfizer and the University of Oxford has led to a number of collaborations with this pharmaceutical partner.
Oxford-BMS Fellowship Programme
An active alliance between Bristol Myers Squibb (formerly Celgene) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
Bayer Alliance in Woman's Health
The University of Oxford is collaborating with Bayer on a number of projects focused around Women’s Health.